Research Conference

Medicines of the Future 2024

Exploring the Future of Biologic Medicines and Advanced Therapies 

Taking place on Friday the 24th of May 2024, 9.00 – 16.45 (Dublin Local Time)

Featuring keynote speakers: 

  • Dr. Larry Bacon, Consultant Haematologist, St James Hospital
  • Professor Dame Sarah Gilbert DBE FRS, Saïd Professor of Vaccinology, University of Oxford, UK.
  • Dr. Brian Harrison, Managing Director, HiTech Health
  • Professor Nicki Panoskaltsis, Professor in Personalised Therapeutics, School of Pharmacy & Pharmaceutical Sciences, Trinity College Dublin and St. James's Hospital
  • Dr. Bernie Sweeney, Head of the Cell Expression Centre of Excellence, BioR&D Lonza

 

Conference speaker topics include: 

Development and Manufacture of Cell Therapies

Vaccine Manufacture, Translation & Acceptance

Cell Expression Systems and Processes used to Manufacture Advanced Biotherapeutics 

Development and Manufacture of Protein-Based Therapies / Multispecific Therapies

Research at NIBRT 

NIBRT Research is a world leader in developing innovative technologies that advance biopharmaceutical manufacturing and a resource for the global biopharmaceutical industry. Inspired by the manufacturing challenges facing the industry, NIBRT Research makes transformative discoveries across multidisciplinary areas such as analytical science, cell and genetic engineering, informatics, and bioprocess engineering. These discoveries are utilised to advance the state-of-the-art in their fields and revolutionise the manufacturing of recombinant proteins, vaccines and cell and gene therapies.

NIBRT's recent large scale expansion to our existing facility includes five new laboratories dedicated to research in advanced therapies. This expansion will increase NIBRT’s capability in Advanced Therapy Medicinal Products (ATMPs) including Cell and Gene Therapy (CGT) research and training. The €21 million project is funded by the IDA Ireland and the Government of Ireland and will become an integral part in placing Ireland at the forefront of ATMP research, training and innovation.

3635_088D_Small 2
3635_088D_Small 3

About NIBRT 

NIBRT supports the growth and advancement of the biopharma manufacturing industry by offering state-of-the-art training and research solutions. Through a unique collaboration between industry, government, and academia, NIBRT opened its world-class facility in Dublin, Ireland in 2011.

The facility was primarily funded by IDA Ireland (Industrial Development Agency), Ireland's inward investment promotion agency, which is dedicated to attracting and developing foreign investment in Ireland. As a result, NIBRT provides an unparalleled training and research experience that was previously unavailable anywhere in the world